TriloDocs is proud to announce that we have recently been acquired by Genactis: a global leader in healthcare research and technology.
TriloDocs is an AI tool that generates an initial draft of a Clinical Study Report (CSR). Pulling data from all source documents, the 1st draft report accurately reflects the input material (clinical protocol, statistical analysis plan, and the data tables and figures), leaving the crafting of the messages to the medical writer and the clinical team.
The output is a Word file in the Transcelerate template (adaptable on request). Methods are generated from protocol, amendments, and Statistical Analysis Plan.
Results are generated from the TLFs creating text and in-text tables for all key parameters.
Focus is on highlighting clinically relevant findings – identifying cutoffs and decision points for transparency and clarity.
Building on years of knowledge from expert medical writers and combining this with the latest AI technology, we created a tool that is easy to use and incredibly powerful.
https://www.youtube.com/@TriloDocs
Company Details
- Employees
- 7
- Address
- London, Gb
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- https://trilodocs.com
- Keywords
- International (CSI).
- HQ
- London
Trilodocs (Part Of Genactis Group) Questions
Trilodocs (Part Of Genactis Group)'s website is https://trilodocs.com
Trilodocs (Part Of Genactis Group)'s LinkedIn profile is https://uk.linkedin.com/company/trilodocs
Trilodocs (Part Of Genactis Group) has
7 employees.
View email and phone details for 7
employees at Trilodocs (Part Of Genactis Group).
Trilodocs (Part Of Genactis Group)'s industry is
Software Development
Trilodocs (Part Of Genactis Group)'s top competitors are
Guy's And St Thomas' Nhs Foundation Trust,
Armstrong,
Medpace,
Malaberg,
Corti,
Openai,
Genactis Ltd,
Trilogy Writing & Consulting, An Indegene Company,
Path,
Indegene.
Trilodocs (Part Of Genactis Group)'s categories are Software Development
